Intercept Pharmaceuticals (Nasdaq: ICPT) is up modestly following the company's presentation at the JPMorgan healthcare conference Wednesday.

This article: 90 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE